» Authors » Sachin Paranjape

Sachin Paranjape

Explore the profile of Sachin Paranjape including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Okamoto L, Walsh E, Diedrich A, Shibao C, Gamboa A, Black B, et al.
Hypertension . 2024 Dec; 82(3):489-497. PMID: 39727053
Background: The cholinesterase inhibitor pyridostigmine is used to treat orthostatic hypotension by facilitating cholinergic neurotransmission in autonomic ganglia, thereby harnessing residual sympathetic tone to increase blood pressure (BP) preferentially in...
2.
Birdee G, Nelson K, Wallston K, Nian H, Diedrich A, Paranjape S, et al.
Complement Ther Med . 2023 Mar; 73:102937. PMID: 36871835
Introduction: Slow breathing techniques are commonly used to reduce stress. While it is believed by mind-body practitioners that extending the exhale time relative to inhale increases relaxation, this has not...
3.
Chopoorian A, Wahba A, Celedonio J, Nwazue V, Smith E, Garland E, et al.
Hypertension . 2021 Jan; 77(3):1001-1009. PMID: 33486983
The purpose of this study is to evaluate endothelial function in postural tachycardia syndrome (PoTS), a poorly understood chronic condition characterized by a state of consistent orthostatic tachycardia (delta heart...
4.
Hartwig C, Sprick J, Jeong J, Hu Y, Morison D, Stein C, et al.
Am J Physiol Regul Integr Comp Physiol . 2020 Sep; 319(6):R611-R616. PMID: 32966119
Posttraumatic stress disorder (PTSD) is an independent risk factor for the development of hypertension and cardiovascular disease. Patients with PTSD have heightened blood pressure and sympathetic nervous system reactivity; however,...
5.
Joish V, Zhou F, Preblick R, Lin D, Deshpande M, Verma S, et al.
J Manag Care Spec Pharm . 2020 Feb; 26(3):311-318. PMID: 32105172
Background: Diabetes health care resource utilization (HCRU) studies tend to focus on patients with type 2 diabetes (T2D) or pool patients with T2D and type 1 diabetes (T1D). There is...
6.
Edelman S, Zhou F, Preblick R, Verma S, Paranjape S, Davies M, et al.
Pharmacoecon Open . 2020 Jan; 4(3):519-528. PMID: 31997126
Background And Objectives: The burden imposed by cardiovascular disease (CVD) on patients with type 1 diabetes (T1D) in the US has not been thoroughly addressed. In a retrospective observational analysis...
7.
Davidson J, Stager W, Paranjape S, Berria R, Leiter L
Clin Diabetes Endocrinol . 2020 Jan; 6:2. PMID: 31956422
Background: To examine the impact on glycemic control of achieving postprandial glucose (PPG) target with lixisenatide, a once-daily glucagon-like peptide-1 receptor agonist approved in the US, in patients with uncontrolled...
8.
Pettus J, Zhou F, Shepherd L, Mercaldi K, Preblick R, Hunt P, et al.
Diabetes Obes Metab . 2019 Dec; 22(4):622-630. PMID: 31789439
Aims: To use electronic health record data from real-world clinical practice to assess demographics, clinical characteristics and disease burden of adults with type 1 diabetes (T1D) in the United States....
9.
Pettus J, Zhou F, Shepherd L, Preblick R, Hunt P, Paranjape S, et al.
Diabetes Care . 2019 Sep; 42(12):2220-2227. PMID: 31548241
Objective: To assess the burden of disease for adults with type 1 diabetes in a U.S. electronic health record database by evaluating acute and microvascular complications stratified by age and...
10.
Sprick J, Morison D, Stein C, Li Y, Paranjape S, Fonkoue I, et al.
Am J Physiol Regul Integr Comp Physiol . 2019 Jul; 317(3):R485-R490. PMID: 31314543
Chronic kidney disease (CKD) is often complicated by difficult-to-control hypertension, in part due to chronic overactivation of the sympathetic nervous system (SNS). CKD patients also exhibit a greater increase in...